Sterne Agee Group’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q1
$4.63M Buy
171,346
+4,406
+3% +$101K 0.68% 34
2014
Q4
$3.53M Buy
166,940
+2,516
+2% +$56.2K 0.55% 47
2014
Q3
$3.94M Sell
164,424
-3,582
-2% -$82.4K 0.63% 37
2014
Q2
$3.88M Buy
168,006
+2,498
+2% +$55.2K 0.65% 39
2014
Q1
$3.78M Buy
+165,508
New +$3.53M 0.74% 27
2013
Q4
Sell
-74,510
Closed -$1.26M 260
2013
Q3
$1.26M Buy
74,510
+11,760
+19% +$198K 0.49% 51
2013
Q2
$972K Buy
+62,750
New +$1.04M 0.35% 80

Other funds holding NVO

Sterne Agee Group's NVO Position: Q1 2015 in Review

Sterne Agee Group increased its Novo Nordisk (NVO) stake by 2.6% in Q1 2015, buying an estimated $101K and bringing the position to 171,346 shares worth $4.63M. The position accounts for 0.68% of the portfolio, ranked #34.

Sterne Agee Group first reported a position in NVO in Q2 2013 and has held it in 7 quarters since. 505 funds tracked by Wall St. Rank hold NVO as of Q1 2015.

  • Sterne Agee Group held 171,346 shares of Novo Nordisk worth $4.63M as of Q1 2015.
  • Sterne Agee Group bought 4,406 Novo Nordisk shares in Q1 2015, an estimated $101K.
  • Novo Nordisk made up 0.68% of Sterne Agee Group's portfolio in Q1 2015, its #34 holding.
  • Sterne Agee Group first reported a position in Novo Nordisk in Q2 2013 and has held it in 7 quarters since.
  • 505 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2015.

Based on Sterne Agee Group's 13F filing for Q1 2015, filed 13 May 2015.